Comparison of Fractional Inhibitory Concentration Index with Response Surface Modeling for Characterization of In Vitro Interaction of Antifungals against Itraconazole-Susceptible and -ResistantAspergillus fumigatusIsolates
Open Access
- 1 March 2002
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 46 (3) , 702-707
- https://doi.org/10.1128/aac.46.3.702-707.2002
Abstract
Although the fractional inhibitory concentration (FIC) index is most frequently used to define or to describe drug interactions, it has some important disadvantages when used for drugs against filamentous fungi. This includes observer bias in the determination of the MIC and no agreement on the endpoints (MIC-0, MIC-1, or MIC-2 [≥95, ≥75, and ≥50% growth inhibition, respectively]) when studying drug combinations. Furthermore, statistical analysis and comparisons are troublesome. The use of a spectrophotometric method to determine the effect of drug combinations yields quantitative data and permits the use of model fits to the whole response surface. We applied the response surface model described by Greco et al. (W. R. Greco, G. Bravo, and J. C. Parsons, Pharmacol. Rev. 47:331-385, 1995) to determine the interaction coefficient alpha (ICα) using a program developed for that purpose and compared the results with FIC indices. The susceptibilities of amphotericin B (AM), itraconazole (IT), and terbinafine (TB) were tested either alone or in combination against 10 IT-susceptible (IT-S) and 5 IT-resistant (IT-R) clinical strains ofAspergillus fumigatususing a modified checkerboard microdilution method that employs the dye MTT [3-(4,5-dimethyl-2-thiazyl)2,5-diphenyl-2H-tetrazolium bromide]. Growth in each well was determined by a spectrophotometer. FIC indices were determined and ICα values were estimated for each organism strain combination, and the latter included error estimates. Depending on the MIC endpoint used, the FIC index ranged from 1.016 to 2.077 for AM-IT, from 0.544 to 1.767 for AM-TB, and from 0.656 to 0.740 for IT-TB for the IT-S strains. For the IT-R strains the FIC index ranged from 0.308 to 1.767 for AM-IT, from 0.512 to 1.646 for AM-TB, and from 0.403 to 0.497 for IT-TB. The results indicate that the degree of interaction is not only determined by the agents themselves but also by the choice of the endpoint. Estimates of the ICα values showed more consistent results. Although the absolute FIC indices were difficult to interpret, there was a good correlation with the results obtained using the ICα values. The combination of AM with either IT or TB was antagonistic in vitro, whereas the combination of IT and TB was synergistic in vitro for both IT-S and IT-R strains. The use of response surface modeling to determine the interaction of drugs against filamentous fungi is promising, and more consistent results are obtained by this method than by using FIC indices.Keywords
This publication has 25 references indexed in Scilit:
- Comparison of Spectrophotometric and Visual Readings of NCCLS Method and Evaluation of a Colorimetric Method Based on Reduction of a Soluble Tetrazolium Salt, 2,3-Bis {2-Methoxy-4-Nitro-5-[(Sulfenylamino) Carbonyl]-2H- Tetrazolium-Hydroxide}, for Antifungal Susceptibility Testing of Aspergillus SpeciesJournal of Clinical Microbiology, 2001
- Antifungal Drug Resistance in AspergillusJournal of Infection, 2000
- Practice Guidelines for the Treatment of TuberculosisClinical Infectious Diseases, 2000
- Practice Guidelines for the Management of Cryptococcal DiseaseClinical Infectious Diseases, 2000
- Mechanism for Synergism between Sulphonamides and Trimethoprim ClarifiedJournal of Pharmacy and Pharmacology, 1996
- Trends in the postmortem epidemiology of invasive fungal infections at a University HospitalJournal of Infection, 1996
- In vitro evaluation of combination of fluconazole and flucytosine against Cryptococcus neoformans var. neoformansAntimicrobial Agents and Chemotherapy, 1995
- Effects of antifungal agent combinations administered simultaneously and sequentially against Aspergillus fumigatusAntimicrobial Agents and Chemotherapy, 1994
- In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agentsDiagnostic Microbiology and Infectious Disease, 1992
- A Method for Testing for Synergy with Any Number of AgentsThe Journal of Infectious Diseases, 1978